|
HACE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.71159994458259E-09 |
| Normal-vs-Stage3 |
7.677700E-02 |
| Normal-vs-Stage4 |
2.333000E-01 |
| Stage1-vs-Stage2 |
2.957800E-01 |
| Stage1-vs-Stage3 |
1.876190E-01 |
| Stage1-vs-Stage4 |
1.740360E-01 |
| Stage2-vs-Stage3 |
3.660600E-01 |
| Stage2-vs-Stage4 |
2.969600E-01 |
| Stage3-vs-Stage4 |
8.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.62880819942757E-12 |
| Normal-vs-Asian |
2.6317000000331E-06 |
| Caucasian-vs-AfricanAmerican |
9.425000E-01 |
| Caucasian-vs-Asian |
9.286600E-01 |
| AfricanAmerican-vs-Asian |
8.757000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.08680000000072E-05 |
| Male-vs-Female |
5.081000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.506410E-02 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
<1E-12 |
| Normal-vs-Extreme_Obese |
3.524400E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.818000E-02 |
| Normal_Weight-vs-Obese |
1.044960E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.488400E-01 |
| Extreme_Weight-vs-Obese |
9.881200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.166400E-01 |
| Obese-vs-Extreme_Obese |
7.602600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30850000004779E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(81-100Yrs) |
1.21447296663746E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.104400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.817440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.932150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.215600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.248010E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.517800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.9025999999922E-06 |
| Normal-VS-KIRP CIMP |
2.416000E-04 |
| Normal-VS-Unclassified PRCC |
2.55329091203294E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.488800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.296320E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.982000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.599000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.085600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.629600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.89768209427166E-14 |
| Normal-vs-N1 |
4.200800E-01 |
| Normal-vs-N2 |
1.02540000002094E-06 |
| N0-vs-N1 |
1.023240E-01 |
| N0-vs-N2 |
5.413000E-01 |
| N1-vs-N2 |
4.530000E-02 |
|
|
